Report Detail

Medical Devices United States Interventional Cardiology Devices Market Report 2017

  • RnM1220256
  • |
  • 2 May, 2017
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Medical Devices

United States Interventional Cardiology Devices Market Report 2017

Table of Contents

    United States Interventional Cardiology Devices Market Report 2017

      1 Interventional Cardiology Devices Overview

      • 1.1 Product Overview and Scope of Interventional Cardiology Devices
      • 1.2 Classification of Interventional Cardiology Devices by Product Category
        • 1.2.1 United States Interventional Cardiology Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
        • 1.2.2 United States Interventional Cardiology Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        • 1.2.3 Stents
        • 1.2.4 Catheters
        • 1.2.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
        • 1.2.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide wires
        • 1.2.7 Others
      • 1.3 United States Interventional Cardiology Devices Market by Application/End Users
        • 1.3.1 United States Interventional Cardiology Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Other
      • 1.4 United States Interventional Cardiology Devices Market by Region
        • 1.4.1 United States Interventional Cardiology Devices Market Size (Value) Comparison by Region (2012-2022)
        • 1.4.2 The West Interventional Cardiology Devices Status and Prospect (2012-2022)
        • 1.4.3 Southwest Interventional Cardiology Devices Status and Prospect (2012-2022)
        • 1.4.4 The Middle Atlantic Interventional Cardiology Devices Status and Prospect (2012-2022)
        • 1.4.5 New England Interventional Cardiology Devices Status and Prospect (2012-2022)
        • 1.4.6 The South Interventional Cardiology Devices Status and Prospect (2012-2022)
        • 1.4.7 The Midwest Interventional Cardiology Devices Status and Prospect (2012-2022)
      • 1.5 United States Market Size (Value and Volume) of Interventional Cardiology Devices (2012-2022)
        • 1.5.1 United States Interventional Cardiology Devices Sales and Growth Rate (2012-2022)
        • 1.5.2 United States Interventional Cardiology Devices Revenue and Growth Rate (2012-2022)

      2 United States Interventional Cardiology Devices Market Competition by Players/Suppliers

      • 2.1 United States Interventional Cardiology Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
      • 2.2 United States Interventional Cardiology Devices Revenue and Share by Players/Suppliers (2012-2017)
      • 2.3 United States Interventional Cardiology Devices Average Price by Players/Suppliers (2012-2017)
      • 2.4 United States Interventional Cardiology Devices Market Competitive Situation and Trends
        • 2.4.1 United States Interventional Cardiology Devices Market Concentration Rate
        • 2.4.2 United States Interventional Cardiology Devices Market Share of Top 3 and Top 5 Players/Suppliers
        • 2.4.3 Mergers & Acquisitions, Expansion in United States Market
      • 2.5 United States Players/Suppliers Interventional Cardiology Devices Manufacturing Base Distribution, Sales Area, Product Type

      3 United States Interventional Cardiology Devices Sales (Volume) and Revenue (Value) by Region (2012-2017)

      • 3.1 United States Interventional Cardiology Devices Sales and Market Share by Region (2012-2017)
      • 3.2 United States Interventional Cardiology Devices Revenue and Market Share by Region (2012-2017)
      • 3.3 United States Interventional Cardiology Devices Price by Region (2012-2017)

      4 United States Interventional Cardiology Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

      • 4.1 United States Interventional Cardiology Devices Sales and Market Share by Type (Product Category) (2012-2017)
      • 4.2 United States Interventional Cardiology Devices Revenue and Market Share by Type (2012-2017)
      • 4.3 United States Interventional Cardiology Devices Price by Type (2012-2017)
      • 4.4 United States Interventional Cardiology Devices Sales Growth Rate by Type (2012-2017)

      5 United States Interventional Cardiology Devices Sales (Volume) by Application (2012-2017)

      • 5.1 United States Interventional Cardiology Devices Sales and Market Share by Application (2012-2017)
      • 5.2 United States Interventional Cardiology Devices Sales Growth Rate by Application (2012-2017)
      • 5.3 Market Drivers and Opportunities

      6 United States Interventional Cardiology Devices Players/Suppliers Profiles and Sales Data

      • 6.1 Abbott Laboratories
        • 6.1.1 Company Basic Information, Manufacturing Base and Competitors
        • 6.1.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.1.2.1 Product A
          • 6.1.2.2 Product B
        • 6.1.3 Abbott Laboratories Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.1.4 Main Business/Business Overview
      • 6.2 B. Braun Melsungen
        • 6.2.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.2.2.1 Product A
          • 6.2.2.2 Product B
        • 6.2.3 B. Braun Melsungen Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.2.4 Main Business/Business Overview
      • 6.3 Medtronic
        • 6.3.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.3.2.1 Product A
          • 6.3.2.2 Product B
        • 6.3.3 Medtronic Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.3.4 Main Business/Business Overview
      • 6.4 Smiths Medical
        • 6.4.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.4.2.1 Product A
          • 6.4.2.2 Product B
        • 6.4.3 Smiths Medical Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.4.4 Main Business/Business Overview
      • 6.5 Boston Scientific
        • 6.5.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.5.2.1 Product A
          • 6.5.2.2 Product B
        • 6.5.3 Boston Scientific Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.5.4 Main Business/Business Overview
      • 6.6 Cook Medical
        • 6.6.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.6.2.1 Product A
          • 6.6.2.2 Product B
        • 6.6.3 Cook Medical Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.6.4 Main Business/Business Overview
      • 6.7 Johnson & Johnson (Cordis Corporation)
        • 6.7.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.7.2.1 Product A
          • 6.7.2.2 Product B
        • 6.7.3 Johnson & Johnson (Cordis Corporation) Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.7.4 Main Business/Business Overview
      • 6.8 GE Healthcare
        • 6.8.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.8.2.1 Product A
          • 6.8.2.2 Product B
        • 6.8.3 GE Healthcare Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.8.4 Main Business/Business Overview
      • 6.9 Terumo Corporation
        • 6.9.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.9.2.1 Product A
          • 6.9.2.2 Product B
        • 6.9.3 Terumo Corporation Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.9.4 Main Business/Business Overview
      • 6.10 Volcano Therapeutics
        • 6.10.2 Interventional Cardiology Devices Product Category, Application and Specification
          • 6.10.2.1 Product A
          • 6.10.2.2 Product B
        • 6.10.3 Volcano Therapeutics Interventional Cardiology Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.10.4 Main Business/Business Overview
      • 6.11 Argon Medical
      • 6.12 Merit Medical Systems

      7 Interventional Cardiology Devices Manufacturing Cost Analysis

      • 7.1 Interventional Cardiology Devices Key Raw Materials Analysis
        • 7.1.1 Key Raw Materials
        • 7.1.2 Price Trend of Key Raw Materials
        • 7.1.3 Key Suppliers of Raw Materials
        • 7.1.4 Market Concentration Rate of Raw Materials
      • 7.2 Proportion of Manufacturing Cost Structure
        • 7.2.1 Raw Materials
        • 7.2.2 Labor Cost
        • 7.2.3 Manufacturing Expenses
      • 7.3 Manufacturing Process Analysis of Interventional Cardiology Devices

      8 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 8.1 Interventional Cardiology Devices Industrial Chain Analysis
      • 8.2 Upstream Raw Materials Sourcing
      • 8.3 Raw Materials Sources of Interventional Cardiology Devices Major Manufacturers in 2016
      • 8.4 Downstream Buyers

      9 Marketing Strategy Analysis, Distributors/Traders

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
        • 9.1.3 Marketing Channel Development Trend
      • 9.2 Market Positioning
        • 9.2.1 Pricing Strategy
        • 9.2.2 Brand Strategy
        • 9.2.3 Target Client
      • 9.3 Distributors/Traders List

      10 Market Effect Factors Analysis

      • 10.1 Technology Progress/Risk
        • 10.1.1 Substitutes Threat
        • 10.1.2 Technology Progress in Related Industry
      • 10.2 Consumer Needs/Customer Preference Change
      • 10.3 Economic/Political Environmental Change

      11 United States Interventional Cardiology Devices Market Size (Value and Volume) Forecast (2017-2022)

      • 11.1 United States Interventional Cardiology Devices Sales Volume, Revenue Forecast (2017-2022)
      • 11.2 United States Interventional Cardiology Devices Sales Volume Forecast by Type (2017-2022)
      • 11.3 United States Interventional Cardiology Devices Sales Volume Forecast by Application (2017-2022)
      • 11.4 United States Interventional Cardiology Devices Sales Volume Forecast by Region (2017-2022)

      12 Research Findings and Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources

        In this report, the United States Interventional Cardiology Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

        Geographically, this report splits the United States market into seven regions:
        The West
        Southwest
        The Middle Atlantic
        New England
        The South
        The Midwest
        with sales (volume), revenue (value), market share and growth rate of Interventional Cardiology Devices in these regions, from 2012 to 2022 (forecast).

        United States Interventional Cardiology Devices market competition by top manufacturers/players, with Interventional Cardiology Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
        Abbott Laboratories
        B. Braun Melsungen
        Medtronic
        Smiths Medical
        Boston Scientific
        Cook Medical
        Johnson & Johnson (Cordis Corporation)
        GE Healthcare
        Terumo Corporation
        Volcano Therapeutics
        Argon Medical
        Merit Medical Systems

        On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
        Stents
        Catheters
        Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
        Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide wires
        Others
        On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Interventional Cardiology Devices for each application, including
        Hospital
        Clinic
        Other

        If you have any special requirements, please let us know and we will offer you the report as you want.



        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,800.00
        $7,600.00
        3,042.59
        6,085.18
        3,437.85
        6,875.70
        410,491.20
        820,982.40
        270,843.10
        541,686.20
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report